Sign in

CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company

ACHIEVE LIFE SCIENCES, INC.

Sign in to watch
Ticker
ACHV
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
954343413
Phone
425-686-1500
Business address
22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
Former names
ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
  1. 4 Option exercise Director acquired 2,000 shares (option exercise)
  2. ARS Other Annual Report to Security Holders
  3. 10-Q Report Quarterly Report
  4. 8-K Event Results of operations
  5. DEF 14A Proxy Proxy Statement
  6. UPLOAD Other SEC-generated Letter
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. UPLOAD Other SEC-generated Letter
  9. PRE 14A Proxy Proxy Statement (Preliminary)
  10. 4 Derivatives Options or other derivatives
  11. 4 Shares withheld for taxes EVP, CMO gave up 534 shares (to pay taxes)
  12. 4 Shares withheld for taxes President and CEO gave up 2,134 shares (to pay taxes)
  13. 10-K Report Annual Report
  14. 8-K Event Results of operations
  15. SC 13G/A Stake Amended Statement of Ownership
  16. SC 13G/A Stake Amended Statement of Ownership
  17. SC 13G/A Stake Amended Statement of Ownership
  18. SC 13G/A Stake Amended Statement of Ownership
  19. SC 13G/A Stake Amended Statement of Ownership
  20. SC 13G/A Stake Amended Statement of Ownership

Page 40 of 68 · 1,358 filings